Risk factors

Catheter Precision (VTAK) risk factors

Item 1A of every Catheter Precision, Inc. 10-K on file, and what changed from one year to the next.

Open VTAK in Gloomberb →
  • FY2025 10-K risk factors

    53 risks, 1 new, 2 dropped, 5 reworded since the prior year. Marketing and distribution support is now separately identified as a threat to product acceptance and revenue.

    Filed Mar 31, 2026
  • FY2024 10-K risk factors

    54 risks. Catheter Precision faces going-concern doubts due to persistent cash burn and operating losses from its VIVO System and LockeT products. The company must secure additional funding, build a U.S. sales force, and expand FDA clearances to reach profitability. Pervasive FDA regulations, material financial control weaknesses, and reimbursement hurdles pose ongoing threats.

    Filed Mar 31, 2025